Lluís Ballell

Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis

Lluís Ballell, Robert H. Bates, Rob J. Young et al. · ChemMedChem · 2013 · 308 citations · Full text

Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB

Katherine A. Abrahams, Jonathan A. G. Cox, Vickey L. Spivey et al. · PLoS ONE · 2012 · 176 citations · Full text

Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3

Modesto J. Remuiñán, Esther Pérez‐Herrán, Joaquín Rullás et al. · PLoS ONE · 2013 · 138 citations · Full text

Tuberculosis Prevention, Lead Series, Antimicrobial Chemotherapy +19

Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of <i>Mycobacterium tuberculosis</i> InhA

Lourdes Encinas, Heather P. O’Keefe, Margarete Neu et al. · Journal of Medicinal Chemistry · 2014 · 118 citations · Full text

Bioorganic Chemistry, Hit Identification, Pharmaceutical Chemistry +22

New thiopyrazolo[3,4-d]pyrimidine derivatives as anti-mycobacterial agents

Lluís Ballell, Robert A. Field, Gavin A.C. Chung et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 113 citations

Medicinal Chemistry, Medicine, Anti-mycobacterial Agents +7